GROUNDBREAKING! US FDA accepts Dei BioPharma’s application for groundbreaking biological diabetes and weight loss drug
The U.S. Food and Drug Administration (FDA) has accepted an application from Uganda’s Dei BioPharma for the review of its...
Impact
Our Commitment to Community
Our CSR initiatives target local, national, and global contexts. Our diversified team includes people with roots worldwide. Healthcare is our primary focus, and we ensure that we directly impact the lives of every individual.
Empowering Communities
Providing jobs and opportunities for skilled and unskilled Ugandan workers.
- Creating jobs for skilled and unskilled Ugandan workers.
- Providing workforce training in biotechnology and pharmaceuticals.
- Ensuring inclusive hiring and empowering women in the workforce.
Promoting Sustainability
Implementing eco-friendly practices in manufacturing.
- Implementing eco-friendly manufacturing to reduce waste.
- Ensuring ethical sourcing and a sustainable supply chain.
- Using energy-efficient processes and water recycling systems.
Improving Healthcare Access
Offering affordable medicines and vaccines to the unprivileged.
- Producing affordable medicines and vaccines for underserved communities.
- Partnering with NGOs to provide free and subsidized healthcare.
- Innovating treatments for malaria, cancer, and critical diseases.
Education & Training
We partner with local universities to provide internships and training programs.
- Offering internships and training through university partnerships.
- Supporting STEM education with scholarships and workshops.
- Providing industry certifications to enhance career prospects.
Our latest News & Blogs
What is a CDMO? Understanding the Backbone of Modern Drug Development in Africa
Learn how Contract Development and Manufacturing Organizations(CDMOs) like Dei Biopharma are transforming pharmaceutical manufacturing in Uganda and across Africa.
GLP-1 Receptor Agonists: Chemical Evolution and Expanding Clinical Applications
Matthias Magoola DEI Biopharma, Kampala, Uganda; dei@deigroupinternational.com Abstract: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed modern medicine, progressing from diabetes treatments to...